Peroxisome proliferator-activated receptor γ polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy

Autor: Yao, Q., Nordfors, L., Axelsson, J., Heimbürger, O., Qureshi, A.R., Báràny, P., Lindholm, B., Lönnqvist, F., Schalling, M., Stenvinkel, P. *
Zdroj: In Atherosclerosis 2005 182(1):105-111
Databáze: ScienceDirect